[1. Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010;30(4):708-49.]Search in Google Scholar
[2. Marzano C, Pellei M, Tisato F, Santini C. Copper Complexes as Anticancer Agents. Anticancer Agents Med Chem. 2009;9:185-211.10.2174/187152009787313837]Search in Google Scholar
[3. Prudhomme M. Advances in Anticancer Agents in Medicinal Chemistry. Clermont-Ferrand: Bentham Science Publishers; 2013(2).10.2174/97816080549611130201]Search in Google Scholar
[4. Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C. Advances in copper complexes as anticancer agents. Chem Rev. 2014;114(1):815-62.10.1021/cr400135x]Search in Google Scholar
[5. Marcel, Gielen, Tiekink, Edward. Metallotherapeutic drugs and metal-based diagnostic agents. Chichester: John Wiley & Sons Ltd; 2005.10.1002/0470864052]Search in Google Scholar
[6. Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer. 2004;11(2):255-63.10.1677/erc.0.0110255]Search in Google Scholar
[7. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O’Halloran TV. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science. 1999;284:805-8.10.1126/science.284.5415.805]Search in Google Scholar
[8. Daniel KG, Harbach RH, Guida WC, Dou QP. Copper storage diseases: Menkes, Wilson’s, and cancer. Front Biosci. 2004;9:2652-62.10.2741/1424]Search in Google Scholar
[9. Molina-Holgado F, Hider RC, Gaeta A, Williams R, Francis P. Metals ions and neurodegeneration. Biometals. 2007;20:639-54.10.1007/s10534-006-9033-z]Search in Google Scholar
[10. Iakovidis I, Delimaris I, Piperakis SM. Copper and its complexes in medicine: a biochemical approach. Mol Biol Int. 2011;2011:594529.10.4061/2011/594529]Search in Google Scholar
[11. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radic Biol Med. 1985;1:3-25.10.1016/0748-5514(85)90025-X]Search in Google Scholar
[12. Daniel KG, Gupta P, Harbach RH, Guida WC, Dou QP. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells. Biochem Pharmacol. 2004;67:1139-51.10.1016/j.bcp.2003.10.031]Search in Google Scholar
[13. Chhakkar Ak, Kakkar LR. Extractive-spectrophotometric method for the determination of palladium using thiosalicylic acid and hexylamine. Fresenius J Anal Chem. 1993;347(12):483-5.10.1007/BF00324239]Search in Google Scholar
[14. Gregory GREC and Jeffery PG. Salicylideneamino-2-thiophenol a new reagent for the photometric determination of tin: application to the analysis of ores, rocks and minerals. Analyst. 1967;92:293-9.10.1039/AN9679200293]Search in Google Scholar
[15. Gismera MJ, Procopio JR, Sevilla MT, Hernandez L. Copper(II) ion-selective electrodes based on dithiosalicylic and thiosalicylic acids. Electroanalysis. 2003;15(2):126-32.10.1002/elan.200390013]Search in Google Scholar
[16. Aydin M, Arsu N, Yagci Y. One-component biomolecular photoinitiating systems. Macromol Rapid Commun. 2003;24:718-23.10.1002/marc.200300019]Search in Google Scholar
[17. Shander D, Ahluwalia G, Grosso D. Us Patent 5411991.]Search in Google Scholar
[18. Tarbet B. Skin disorders, therapy using fungicides. U.S. Patent Application No. 10/706,708.]Search in Google Scholar
[19. Jacobelli H. US Patent 20050267095.]Search in Google Scholar
[20. Halaschek-Wiener J, Kloog Y, Wacheck V, Jansen B. Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo. J Invest Dermatol. 2003;120(1):109-15.10.1046/j.1523-1747.2003.12009.x]Search in Google Scholar
[21. O’Halloran TV. Transition metals in control of gene expression. Science. 1993;261(5122):715-25.10.1126/science.8342038]Search in Google Scholar
[22. Ferrer EG, Williams PAM. Synthesis and characterization of dimeric complex of Cu(II) with thiosalicylic acid and pyridine. Polyhedron. 1997;16(19):3323-5.10.1016/S0277-5387(97)00081-8]Search in Google Scholar
[23. Bott RC, Healy PC, Sagatysb DS. Electrochemical synthesis and structural characterization of the trinuclear copper(I)-copper(II) complex: bis[bis(triphenylphosphine) copper(I)][bis(thiosalicylate)copper(II)]. Chem Commun. 1998;2403-4. 10.1039/a806813e]Search in Google Scholar
[24. Nikolić MV, Mijajlović MŽ, Jevtić VV, Ratković ZR, Radojević ID, Čomić LjR et al. Synthesis, characterization and antimicrobial activity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-methyl derivatives of thiosalicylic acid. Polyhedron. 2014;79:80-7.10.1016/j.poly.2014.04.053]Search in Google Scholar
[25. Nikolić MV, Mijajlović MŽ, Jevtić VV, Ratković ZR, Novaković SB, Bogdanović GA et al. Cytotoxicity of copper(II)-complexes with some S-alkyl derivatives of thiosalicylic acid. Crystal structure of the binuclear copper(II)-complex with S-ethyl derivatives of thiosalicylic acid. Journal of Molecular Structure. 2016;1116:264-71.10.1016/j.molstruc.2016.03.058]Search in Google Scholar
[26. Radić GP, Glođović VV, Radojević ID, Stefanović OD, Čomić LjR, Ratković ZR et al. Synthesis, characterization and antimicrobial activity of palladium(II) complex with same alkyl derivates of thiosalicylic acids: Crystal structure of the bis(S-benzyl-thiosalicylate)--palladium( II)-complex, [Pd(S-bz thiosal)2]. Polyhedron. 2012;31(1):69-76.10.1016/j.poly.2011.08.042]Search in Google Scholar
[27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.10.1016/0022-1759(83)90303-4]Search in Google Scholar
[28. Schoenberg LN, Cooke DW, Liu CF. Nuclear magnetic resonance determination of the absolute configuration of complexes of cobalt(III) with asymmetric tetradentate ligands. Inorg Chem. 1968;7:2386-93.10.1021/ic50069a040]Search in Google Scholar
[29. Swaminathan K, Busch DH. The synthesis and infrared absorption spectra of complexes of cobalt with pentadentate propylenediaminetetraacetic acid. J Inorg Nucl Chem. 1961;20(1):159-63.10.1016/0022-1902(61)80475-2]Search in Google Scholar
[30. Nakamoto К. Infrared spectra of the inorganic and coordination compounds. New York: Willey; 1963.]Search in Google Scholar
[31. Ferrer, EG, PAM Williams. Synthesis and characterization of a dimeric complex of Cu(II) with thiosalicylic acid and pyridine. Polyhedron. 1997;16(19):3323-5.10.1016/S0277-5387(97)00081-8]Search in Google Scholar
[32. Elmali A. The magnetic super-exchange coupling in copper(II) acetate monohydrate and a redetermination of the crystal structure. Turkish Journal of Physics. 2000;24:667-72.]Search in Google Scholar
[33. Jotham RW, Kettle SFA, Marks JA. Antiferromagnetism in transition-metal complexes. Part VI. Low-lying excited states of dinuclear copper(II) complexes with bridging multidentate Schiff’s base groups and some related compounds. J Chem Soc, Dalton Trans. 1974;2:125-8.]Search in Google Scholar
[34. Meier JL, Coughenour CE, Carlisle JA, Carlisle GO. The magnetic properties of a series of copper(II) aspirinates. Inorg Chim Acta. 1985;106:159-63.10.1016/S0020-1693(00)87552-0]Search in Google Scholar
[35. Underhill AE, Bougourd SA, Flugge ML, Gale SE, Gomm PS. Metal complexes of anti- -inflammatory drugs. Part VIII: Suprofen complex of copper(II). J Inorg Biochem. 1993; 144:139-44. 10.1016/0162-0134(93)85030-C]Search in Google Scholar